Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A

Request For Quotation
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A Suppliers list
Company Name: SHANGHAI FORTUNE CHEMICAL TECHNOLOGY CO., LTD  
Tel: 13816107857
Email: sales@fortunechem-sh.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Changzhou Chenhong Biotechnology Co., Ltd.  
Tel: +86-0519-85788828 +86-13775037613
Email: sales@chemrenpharm.com
Company Name: Wuhan Sunncell Biotech Co., Ltd.  
Tel: 17764018385
Email: 1242926414@qq.com
Company Name: Shanghai Yaji Biological Technology Co., Ltd.  
Tel: 021-34661275 15301693058
Email: yajikit@163.com

Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A manufacturers

  • TP-16
  • TP-16 pictures
  • $1270.00
  • 2026-07-27
  • CAS:2332972-26-4
  • Purity: 99.05%
  • Supply Ability: 10g
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A Basic information
Product Name:Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A
Synonyms:CDKN2A;ANTI-PHOSPHO-P16-INK4A(S152) antibody produced in rabbit;ANTI-PHOSPHO-P16-INK4A(S7) antibody produced in rabbit;ANTI-PHOSPHO-P16-INK4A(S140) antibody produced in rabbit;CDKN2;Cyclin-dependent kinase 4 inhibitor A;Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3;MTS1
CAS:2332972-26-4
MF:C24H22FNO4S
MW:439.5
EINECS:
Product Categories:protein kinase;Elisa Kit-Mouse Elisa Kit
Mol File:2332972-26-4.mol
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A Structure
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A Chemical Properties
storage temp. -20°C
form buffered aqueous solution
biological sourcerabbit
Safety Information
HS Code 3504009000
Storage Class10 - Combustible liquids
MSDS Information
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A Usage And Synthesis
UsesTP-16 is a novel and selective EP4 antagonist with an IC50 of 2.1 nM.
General DescriptionAnti-p14 ARF Antibody detects endogenous levels of total p14 ARF protein.
IC 50EP4: 2.1 nM (IC50)
References[1] Lu W, et al. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. EMBO Mol Med. 2021 Jan 11;13(1):e12798. DOI:10.15252/emmm.202012798
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A Preparation Products And Raw materials
Tag:Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A(2332972-26-4) Related Product Information
S91 MC57G PA12 MODE-K B16-F0 AML12 GC-2 spd K1735 TCMK-1 Ana-1 Mesangial Cells Hca-F LA-795 OSKM-1 NIH3T3 STC1 Mouse Tubular: Normal Tubular Epithelial Cells m-tert-butylphenyl methylcarbamate